NovaBridge Biosciences (NBP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '24: -12.4M Q4 '24: -13.4M Q3 '25: -9M Q4 '25: -72.9M Q3 '24 Q4 '24 Q3 '25 Q4 '25

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -20.5M Q4 '24: -10.8M Q3 '25: -6.8M Q4 '25: -30.8M Q3 '24 Q4 '24 Q3 '25 Q4 '25

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '24: 8.4M Q4 '24: -10.9M Q3 '25: 1.8M Q4 '25: -14.6M Q3 '24 Q4 '24 Q3 '25 Q4 '25

Free Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '24: 8.4M Q4 '24: -11M Q3 '25: 1.8M Q4 '25: -14.6M Q3 '24 Q4 '24 Q3 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.